Heart Valve Disease

23-HVI-4078932_severe-tricuspid-regurgitation_650x450

Early Surgery for Isolated Severe Tricuspid Regurgitation Improves Outcomes

Cleveland Clinic study argues against waiting for symptoms to develop

Blood Clot Cell Artery

PROACT Xa: Apixaban Is Not a Safe Warfarin Substitute With Mechanical Aortic Valve

Details released from the trial halted due to excessive thromboembolic events

23-HVI-3691658 mitral-valve-repair_650x450

Secrets to Success in Mitral Valve Repair

The cultural and technical factors promoting repair durability and a mortality-free stretch of 4,000+ cases

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

23-HVI-3606664 CQD 650×450 (1)

TRILUMINATE Pivotal Trial: What Are Its Implications for Tricuspid Regurgitation Care?

TEER is found to be a safe and good option for severe TR in select patients

23-HVI-3655709 CQD 650×450-c2

MAC Attack: Contending With Mitral Annular Calcification During Mitral Valve Surgery

Surgical tips on debridement of calcification to optimize valve replacement

23-HVI-3606663_CT-of-venae-cavae_650x450

CT Characterization of Venae Cavae Anatomy in Patients With Severe Tricuspid Regurgitation

Understanding VC anatomy is critical for transcatheter tricuspid valve interventions

23-HVI-3606664 CQD 650×450

TAVR With a Balloon-Expandable Valve Is Safe Even When Aortic Annuli Don’t Exactly Match Valve Sizes

Choice between smaller or larger prosthesis is a tradeoff between leak and pacemaker risks

23-HVI-3606658_mitraclip_650x450

Final COAPT Results Show TEER Benefits Through 5 Years in Secondary MR

Superiority continues even after significant crossovers from control group at 2 years

22-HVI-3135510 CQD 650×450

A Closer Look at Tricuspid Regurgitation in Pulmonary Arterial Hypertension

New study illuminates mechanical underpinnings of secondary leaks

BackPage 2 of 5Next

Advertisement

Ad